Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 5, 2012, Pages 453-455

  Jaros, Julian A J ^a   Martins De Souza, Daniel ^a   Rahmoune, Hassan ^a   Schwarz, Emanuel ^a   Leweke, F Markus ^b   Guest, Paul C ^a   Bahn, Sabine ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF COLOGNE   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C8B; COMPLEMENT FACTOR H; DYNEIN HEAVY CHAIN 17; FETUIN A; INTER ALPHA TRYPSIN INHIBITOR; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN H1; KALLISTATIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LETTER; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA;

ADOLESCENT; ADULT; BLOOD PROTEINS; FEMALE; HUMANS; MALE; PHOSPHORYLATION; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84865009280     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-011-0283-6     Document Type: Letter

References (9)

1. Guest PC, Wang L, Harris LW, Burling K, Levin Y, Ernst A, Wayland MT, Umrania Y, Herberth M, Koethe D, van Beveren JM, Rothermundt M, McAllister G, Leweke FM, Steiner J, Bahn S (2010) Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naive schizophrenia patients. Mol Psychiatry 15:118-119
2. Levin Y (2011) The role of statistical power analysis in quantitative proteomics. Proteomics 11:2565-2567
3. Levin Y, Wang L, Schwarz E, Koethe D, Leweke FM, Bahn S (2010) Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol Psychiatry 15:1088-1100
4. Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Wesseling H, Rahmoune H, Bahn S (2011) The need for phosphoproteomic approaches in psychiatric research. J Psychiatr Res 45:1404-1406
5. Mayilyan KR, Weinberger DR, Sim RB (2008) The complement system in schizophrenia. Drug News Perspect 21:200-210
6. Panariello F, Perruolo G, Cassese A, Giacco F, Botta G, Barbagallo AP, Muscettola G, Beguinot F, Formisano P, de Bartolomeis A (2011) Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance. J Cell Physiol. doi:10.1002/jcp.22864
7. Schwarz E, Izmailov R, Spain M, Barnes A, Mapes JP, Guest PC, Rahmoune H, Pietsch S, Leweke FM, Rothermundt M, Steiner J, Koethe D, Kranaster L, Ohrmann P, Suslow T, Levin Y, Bogerts B, van Beveren NJ, McAllister G, Weber N, Niebuhr D, Cowan D, Yolken RH, Bahn S (2010) Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomark Insights 5:39-47
8. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, Machicao F, Fritsche A, Haring HU (2006) Alpha2- Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29:853-857 (Pubitemid 44115306)
9. Walaas SI, Greengard P (1991) Protein phosphorylation and neuronal function. Pharmacol Rev 43:299-349.